University of Ioannina
Μελέτη διαταραχών πήξης του αίματος σε ασθενείς με ηπατικά νοσήματα
Abstract
dc:descriptionLiver cirrhosis is frequently accompanied by profound hemostatic abnormalities. A causal relationship between prolongation of the conventional coagulation tests, such as the prothrombin time (PT) or INR and the activated partial thromboplastin time (APTT), and the risk of bleeding in patients with cirrhosis has been for long time taken for granted though has never been proved. Accordingly, it was widely accepted that these patients were self-anticoagulated and thus protected from thrombotic events. Accumulated evidence, however, indicates that cirrhosis should be no longer considered a hypocoagulable state. Recent findings demonstrated that thrombin generation (TG) is fully preserved or even increased in patients with cirrhosis provided that platelet numbers are sufficient (>60 X109/L) to support the normal TG elicited by plasma. It has also been shown that patients with cirrhosis display a procoagulant imbalance that may be detected by measuring low levels of factors II, V, AT, and PC and high levels of VIII and VIII/PC ratio and is consistent with a state of hypercoagulability. Notably, high levels of vWF, a glycoprotein with major role in platelet aggregation, have been found in patients with cirrhosis thus compensating for deceased number and function of platelets. These findings are in keeping with earlier observations that patients with cirrhosis are not protected from hypercoagulant events, such as portal vein thrombosis (PVT) or other deep venous thromboses, despite their substantial prolongation of conventional coagulation times. Yet, no study has investigated the direct relationship between thrombotic potential and clinical outcome in cirrhotic patients. Consequently, we investigated the magnitude of hypercoagulability in thrombocytopenic patients with cirrhosis of graded severity and patients with chronic liver disease without cirrhosis, as well as the impact of hypercoagulability on the development of portal hypertension-related complications, PVT, and prediction of survival in patients with cirrhosis. Ninty-three patients with liver cirrhosis (Child-Pugh class A/B/C:31/31/31) and thrombocytopenia (platelet count <150X109/L), 40 patients with chronic viral hepatitis without cirrhosis, and 40 healthy subjects were studied. INR, APTT, fibrinogen, procoagulant factors (FII, FV, FVII, FVIII, FIX, FX, FXI, FXII, FXIII), factors related to promotion of hemostasis such as thrombin-antithrombin complexes as TG marker, D-dimers, natural anticoagulant factors (AT, PC, PS), vWF, and VIII/PC ratio were measured in all patients and healthy subjects. Liver disease severity in patients with cirrhosis was evaluated by the Child-Pugh class and the model for end-stage-liver disease (MELD). Eighty-one of 93 patients with platelet count >60X109/L (Child-Pugh class A/B/C:27/27/27) were studied in Protocol A which analyzed INR, APTT, fibrinogen, TAT, D-dimers, AT, PC, PS and MELD. All 93 patients were included in Protocol B which analyzed FII, FV, FVIII, AT, PC, vWF, FVIII/PC ratio, and MELD. Two different multivariate analyses were performed in both Protocols: Model 1, which did not include MELD, and Model 2, which included MELD. In Protocol A, INR was not analyzed concurrently with MELD in Model 2. Our observations strongly suggest a rebalanced hemostatic system in cirrhosis in favour of hypercoagulability. Patients with cirrhosis and high TAT levels, vWF levels and VIII/PC ratio are more likely to develop clinical complications, such as ascites, VB and PVT, and have increased mortality. Measuring the abovementioned parameters could enable risk stratification in patients with cirrhosis and consequently the institution of preventive strategies, which in turn might contribute to improved clinical outcomes.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Oikonomou, Aikaterini-Niki
- Οικονόμου, Αικατερίνη-Νίκη
Subjects
dc:subject × 14Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42391